Uncovering a Novel Molecular Therapeutic Target for HIV-Associated Neurocognitive Impairment
Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only! Grab it Join a seminar from the Joint NIMH Center Series featuring Dr. Reina Bendayan from the University of Toronto as she explores groundbreaking research on molecular therapeutic targets for HIV-Associated Neurocognitive Impairment. Discover the latest findings in neuroHIV research and potential treatment approaches during this hour-long presentation from Johns Hopkins Medicine. Learn about innovative pharmaceutical developments and therapeutic strategies aimed at addressing cognitive impairments in HIV patients. Gain insights from Dr. Bendayan's expertise as a distinguished pharmacologist and fellow of multiple prestigious academic societies (FAAPS, FCSPS, FCAHS) while exploring the intersection of HIV treatment and neurocognitive health.